HK1226079A1 - 线粒体靶向的二羰基螯合化合物 - Google Patents
线粒体靶向的二羰基螯合化合物 Download PDFInfo
- Publication number
- HK1226079A1 HK1226079A1 HK16114224.1A HK16114224A HK1226079A1 HK 1226079 A1 HK1226079 A1 HK 1226079A1 HK 16114224 A HK16114224 A HK 16114224A HK 1226079 A1 HK1226079 A1 HK 1226079A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- mitochondria
- targeted
- salts
- moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Dentistry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1320636.2 | 2013-11-22 | ||
| GBGB1320636.2A GB201320636D0 (en) | 2013-11-22 | 2013-11-22 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1226079A1 true HK1226079A1 (zh) | 2017-09-22 |
Family
ID=49918047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16114224.1A HK1226079A1 (zh) | 2013-11-22 | 2014-11-21 | 线粒体靶向的二羰基螯合化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9963474B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3071582B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6661533B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105873936B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014351802B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2931000A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2802123T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201320636D0 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1226079A1 (cg-RX-API-DMAC7.html) |
| SG (2) | SG11201603485TA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015075200A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201603129B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3562830B1 (en) * | 2016-12-29 | 2023-06-07 | Universidade do Porto | Hydroxybenzoic acid derivatives, methods and uses thereof |
| JP6985730B2 (ja) * | 2017-11-17 | 2021-12-22 | 株式会社日立ハイテクサイエンス | 試料分析システム、表示方法及び試料分析方法 |
| KR101920902B1 (ko) * | 2017-12-27 | 2018-11-21 | 전남대학교 산학협력단 | 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도 |
| WO2020036329A1 (ko) * | 2018-08-16 | 2020-02-20 | 숙명여자대학교산학협력단 | 미토콘드리아 내 nad(p)h 검출을 위한 형광 프로브 및 이를 이용한 검출방법 |
| WO2020154731A1 (en) * | 2019-01-25 | 2020-07-30 | Mti Biotech, Inc. | Triphenylphosphonium-tethered salicylamine derivatives |
| BR112021014696A2 (pt) | 2019-01-25 | 2021-12-28 | Univ Vanderbilt | Sequestrantes isocetais/de isolevuglandina que têm mitocôndria como alvo |
| KR102596981B1 (ko) * | 2019-10-30 | 2023-10-31 | 주식회사 퓨전바이오텍 | 미토콘드리아 표적 화합물 및 이를 포함하는 노화 관련 질환의 치료 또는 예방을 위한 조성물 |
| CA3169467A1 (en) * | 2020-01-27 | 2021-08-05 | Sergey I. Dikalov | Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB926998A (en) * | 1960-04-25 | 1963-05-22 | Ici Ltd | New water-soluble azo dyestuffs containing phosphonium groups |
| JPS52806A (en) | 1975-02-20 | 1977-01-06 | Dai Ichi Kogyo Seiyaku Co Ltd | Preparation of ester |
| JPS6029391B2 (ja) | 1976-02-04 | 1985-07-10 | 富士写真フイルム株式会社 | ベンゾトリアゾ−ル化合物 |
| FR2776289B1 (fr) * | 1998-03-20 | 2001-02-02 | Oreal | Composition de teinture d'oxydation contenant un coupleur cationique, procedes de teinture, nouveaux coupleurs cationiques |
| FR2776290B1 (fr) * | 1998-03-20 | 2001-08-10 | Oreal | Nouveaux composes cationiques, leur utilisation comme coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture |
| FR2788520B1 (fr) * | 1999-01-19 | 2003-02-28 | Oreal | Nouveaux colorants mono-benzeniques cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture |
| CA2431635A1 (en) * | 2001-01-23 | 2002-08-01 | P&G-Clairol, Inc. | Couplers for oxidative coloration of hair |
| CN1678285A (zh) * | 2002-09-02 | 2005-10-05 | 西巴特殊化学品控股有限公司 | 多孔材料的染色方法 |
| EP1818063A1 (en) * | 2004-12-02 | 2007-08-15 | Japan Science and Technology Agency | Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| US7956193B2 (en) | 2007-05-04 | 2011-06-07 | University Of South Florida | Intramolecular C-H amination with sulfonyl azides |
| US8466140B2 (en) | 2007-09-10 | 2013-06-18 | University Of Massachusetts | Mitochondria-targeted anti-tumor agents |
| FR2984321A1 (fr) * | 2011-12-16 | 2013-06-21 | Oreal | Paraphenylenediamines cationiques, composition comprenant au moins de tels composes, procede de mise en oeuvre et utilisation |
| CN102617467A (zh) * | 2012-02-21 | 2012-08-01 | 大连理工大学 | 一种检测一氧化氮的超高灵敏荧光探针 |
| FR2996552B1 (fr) * | 2012-08-17 | 2016-10-14 | Oreal | Composition tinctoriale comprenant un derive o-alkyle substitue de meta-phenylenediamine cationique |
-
2013
- 2013-11-22 GB GBGB1320636.2A patent/GB201320636D0/en not_active Ceased
-
2014
- 2014-11-21 SG SG11201603485TA patent/SG11201603485TA/en unknown
- 2014-11-21 WO PCT/EP2014/075323 patent/WO2015075200A1/en not_active Ceased
- 2014-11-21 SG SG10201807904RA patent/SG10201807904RA/en unknown
- 2014-11-21 ES ES14818889T patent/ES2802123T3/es active Active
- 2014-11-21 EP EP14818889.9A patent/EP3071582B1/en active Active
- 2014-11-21 JP JP2016528880A patent/JP6661533B2/ja not_active Expired - Fee Related
- 2014-11-21 US US15/037,941 patent/US9963474B2/en active Active
- 2014-11-21 CA CA2931000A patent/CA2931000A1/en not_active Abandoned
- 2014-11-21 AU AU2014351802A patent/AU2014351802B2/en not_active Ceased
- 2014-11-21 EP EP19204357.8A patent/EP3623375A1/en not_active Withdrawn
- 2014-11-21 CN CN201480063625.0A patent/CN105873936B/zh not_active Expired - Fee Related
- 2014-11-21 HK HK16114224.1A patent/HK1226079A1/zh unknown
-
2016
- 2016-05-10 ZA ZA2016/03129A patent/ZA201603129B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ719705A (en) | 2021-09-24 |
| AU2014351802B2 (en) | 2019-10-03 |
| SG11201603485TA (en) | 2016-05-30 |
| JP2017504561A (ja) | 2017-02-09 |
| JP6661533B2 (ja) | 2020-03-11 |
| ES2802123T3 (es) | 2021-01-15 |
| ZA201603129B (en) | 2018-12-19 |
| WO2015075200A1 (en) | 2015-05-28 |
| US20160289252A1 (en) | 2016-10-06 |
| CN105873936A (zh) | 2016-08-17 |
| EP3071582A1 (en) | 2016-09-28 |
| AU2014351802A1 (en) | 2016-05-26 |
| US9963474B2 (en) | 2018-05-08 |
| EP3071582B1 (en) | 2020-04-29 |
| CA2931000A1 (en) | 2015-05-28 |
| CN105873936B (zh) | 2018-09-14 |
| EP3623375A1 (en) | 2020-03-18 |
| GB201320636D0 (en) | 2014-01-08 |
| SG10201807904RA (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226079A1 (zh) | 线粒体靶向的二羰基螯合化合物 | |
| CY1123670T1 (el) | Κρυσταλλικο παραγωγο 6,7-ακορεστης-7-καρβαμοϋλ μορφινανης, και μεθοδος για την παραγωγη αυτου | |
| BR112013020996A8 (pt) | derivados aminobutíricos substituídos como inibidores de neprilisina | |
| BR112014031292A2 (pt) | sistema cristalino de múltiplos componentes, processo para obter a composição cristalina, e, composição farmacêutica | |
| MA32941B1 (fr) | Composes organiques | |
| JO3577B1 (ar) | صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| MX350810B (es) | Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc. | |
| EA201990455A1 (ru) | КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ | |
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| CY1117397T1 (el) | Παραγωγα 3-ετεροαρουλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα | |
| CY1118844T1 (el) | Υποκατεστημενα παραγωγα 3-ετεροαροϋλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα | |
| EA201490640A1 (ru) | Замещенные 4,5,6,7-тетрагидро-1h-пиразоло[4,3-c]пиридины, их применение в качестве лекарственного средства и фармацевтические препараты, содержащие их | |
| WO2015011120A3 (en) | Salts of dasatinib in crystalline form | |
| WO2012017434A3 (en) | Guanine nucleotide derivatives for treating bacterial infections | |
| CY1120101T1 (el) | Παραγωγο πυριδονης και φαρμακο που το περιεχει | |
| CY1114704T1 (el) | Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν | |
| WO2010080414A3 (en) | Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents | |
| WO2008024277A3 (en) | Kw-3902 conjugates that do not cross the blood-brain barrier | |
| WO2013074905A3 (en) | Compounds, compositions, pharmaceutical compositions, and methods of use | |
| TH106831A (th) | สารประกอบที่ประกอบด้วยหมู่ไซโคลบิวทอกซีหนึ่งหมู่ | |
| TH158990A (th) | อะโกนิสต์ของจีพีอาร์ 40 | |
| TH153697A (th) | อนุพันธ์ 2-ออกโซ-1-ไพรโรลิดินิล อิมมิดาโซไธอะไดโซล (2-Oxo-1-pyrrolidinyl imidazothiadiazole derivative) | |
| TH174501A (th) | แอริล และเฮเทอโรแอริล ฟิวส์เอดแลคแทม | |
| TH158994A (th) | คาร์บอไซคลิคนิวคลีโอไทด์ และการใช้เชิงเภสัชกรรมของสารเหล่านี้ และองค์ประกอบ |